T338C Src-IN-1 blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
372.44
Molecular Formula
C17H20N6O2S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
T338C Src-IN-1 is designed for research to specifically target mutant Src kinases, offering insights into its role in cancer signaling and development.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
